Comparative efficacy and safety of different traditional Chinese medicine external therapies for polycystic ovary syndrome in women: A network meta-analysis
Abstract
Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases in women. In recent years, traditional Chinese medicine (TCM) treatment has had a positive effect on PCOS, and it is simple, convenient, and inexpensive. The purpose of this study was to compare the efficacy and safety of different external treatments in the treatment of PCOS using a network meta-analysis method.
Methods: The databases examined comprised Web of Science, Embase, PubMed, The Cochrane Library, China National Knowledge Infrastructure, VIP, Wanfang Data Knowledge Service Platform, and the China Biomedical Literature Database. Since the establishment of the database, randomized controlled trials related to TCM external treatment for PCOS have been screened. The literature was derived from follicle-stimulating hormone (FSH), luteinizing hormone (LH), LH/FSH ratios, body mass index, and testosterone, with detrimental impacts identified as the primary outcomes of the screening process. Odds ratio values with 95% confidence intervals and standardized mean difference values were used as performance measures to compare the effects of different interventions and rank them. The above data were statistically analyzed using STATA 17.0 software.
Results: Electroacupuncture has the highest cumulative probability of increasing FSH levels (surface under the cumulative ranking curve [SUCRA]: 86%) and is considered the best intervention to improve FSH in patients with PCOS. Regulating the…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.